Martino Picardo
Chairman at the VisusNano.
Martino is now an Independent Consultant, based in Manchester. He currently has a part-time role as Entrepreneur in Residence at UMIP, Manchester. In addition, Martino is working part-time with the NHS in Manchester, also as an entrepreneur in residence. From June 2011- July 2017, Martino was the first CEO of the Stevenage Bioscience Catalyst an ambitious concept to develop an Incubator and Accelerator, followed by a world class Science Park for the Life Sciences sector. Martino has a PhD in Biochemistry from Cardiff University and spent 4 years at Baylor College of Medicine, Houston, TX in Cardiovascular research. Martino joined Amersham International in 1991 and subsequently went on to manage the R&D Technology Transfer Group, based in Cardiff and developing high throughput screening technologies for the Pharmaceutical sector. Following the merger of Amersham with Pharmacia Biotech, Martino became the Science Director for the Cardiff site, Martino then became a Business Manager for Manchester Biotech Ltd. and subsequently Manchester Innovation Ltd. in June 1999. When the Universities of Manchester and UMIST merged, he became Managing Director of UMIC and MICL and was also a Board member of UKBI (UK Business Incubation).
Visit website: https://www.visusnano.com/our-team/
See also: VisusNano - Revolutionising Treatment for Cataracts.
Details last updated 17-Apr-2021
Martino Picardo is also referenced in the following:
UK SPINE 2021 Annual conference
21-Apr-2021 to 23-Apr-2021
Series of events focused on research and innovation in geroscience and ageing therapeutics organized by UK SPINE.